Advances and Challenges Regarding American Tegumentary Leishmaniasis in the Amazon: Scientific, Epidemiological and Public Health Perspectives
Authors:
- Jorge Augusto de Oliveira GuerraJGJorge Augusto de Oliveira Guerra
- Débora Raysa Teixeira de SousaDSDébora Raysa Teixeira de Sousa
- Silmara Navarro PenniniSPSilmara Navarro Pennini
- Thamires Bastos PinheiroTPThamires Bastos Pinheiro
- Melissa Melo CavalcanteMCMelissa Melo Cavalcante
- Luciana MendesLMLuciana Mendes
- Diego CarvalhoDCDiego Carvalho
- Fábio BorgonovoFBFábio Borgonovo
- Francisco Mateus JoãoFJFrancisco Mateus João
- Isolda Prado de Negreiros Nogueira MaduroIMIsolda Prado de Negreiros Nogueira Maduro
- Luiz Carlos Cunha MarquesLMLuiz Carlos Cunha Marques
- Silvia Cassia Brandão JustinianoSJSilvia Cassia Brandão Justiniano
Open Access
- 1 January 2026
- journal article
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 59 (suppl 1)
Abstract
American tegumentary leishmaniasis (ATL) remains a significant public health problem in the Americas, with the Amazon region standing out in Brazil for its high number of cases. This article aimed to present advances in the understanding of epidemiology, diagnosis, treatment and control of ATL in the state of Amazonas over the past decades. This study is a narrative review of scientific studies published in the literature between 2011 and 2025, retrieved from databases such as PubMed and SciELO, as well as public data from the Notifiable Diseases Information System (SINAN), official reports from the Ministry of Health and technical notes from the Amazonas Health Surveillance Foundation. The evolution of disease incidence is reported, highlighting the predominance of Leishmania (Viannia) guyanensis and the environmental factors associated with the increase in cases, such as deforestation and unplanned urbanization. Advances in diagnostic strategies include the expanded use of molecular techniques and the strengthening of the primary healthcare network. Regarding therapy, clinical trials with drugs such as pentamidine, miltefosine, tamoxifen and itraconazole have demonstrated their efficacy in treatment. The review also includes socio-environmental, genetic and experimental studies that have contributed to a better understanding of the disease. It emphasizes the need to establish a priority agenda that includes the use of telemedicine and the institutionalization of collaborative research for therapeutic innovation, integration between research and healthcare services and strategies adapted to the Amazonian context. Regional scientific advances can support more effective control policies and reduce the burden of ATL in this highly endemic setting.Keywords
This publication has 25 references indexed in Scilit:
- Telemedicine (mobile-Health) as an alternative in the follow-up of patients in a randomized clinical trial for the treatment of cutaneous leishmaniasis in the state of Amazonas, BrazilAnais Brasileiros de Dermatologia, 2025
- Treatment of cutaneous leishmaniasis with a sequential scheme of pentamidine and tamoxifen in an area with a predominance of Leishmania (Viannia) guyanensis: A randomised, non‐inferiority clinical trialTropical Medicine & International Health, 2023
- Association of miltefosine with granulocyte and macrophage colony-stimulating factor (GM-CSF) in the treatment of cutaneous leishmaniasis in the Amazon region: A randomized and controlled trialInternational Journal of Infectious Diseases, 2021
- Failure of fluconazole in treating cutaneous leishmaniasis caused by Leishmania guyanensis in the Brazilian Amazon: An open, nonrandomized phase 2 trialPLOS Neglected Tropical Diseases, 2018
- Ecology, feeding and natural infection by Leishmania spp. of phlebotomine sand flies in an area of high incidence of American tegumentary leishmaniasis in the municipality of Rio Branco, Acre, BrazilParasites & Vectors, 2018
- Leishmaniasis: a reviewF1000Research, 2017
- Record-breaking warming and extreme drought in the Amazon rainforest during the course of El Niño 2015–2016Scientific Reports, 2016
- Evaluation of different diagnostic methods of American Cutaneous Leishmaniasis in the Brazilian AmazonExperimental Parasitology, 2016
- Characterization of Leishmania spp. causing cutaneous leishmaniasis in Manaus, Amazonas, BrazilParasitology Research, 2010
- The ecology of lutzomyia umbratilis Ward & Fraiha (Diptera: Psychodidae), the major vector to man of Leishmania braziliensis guyanensis in north-eastern Amazonian brazilBulletin of Entomological Research, 1986